Objective To investigate the effect of kaempferol on the proliferation,migration,invasion,and apoptosis of human hepatoma Bel-7402 cells and related molecular mechanism. Methods Hepatoma Bel-7402 cells cultured in vitro were randomly divided into control group and low-,middle-,and high-concentration experimental groups. The experimental groups were treated with low-,middle-,and high-concentration kaempferol( 25,50,and 100 μmol/L),and the control group was treated with an equal volume of dimethyl sulfoxide. CCK-8 assay was used to observe the effect of kaempferol on the viability of Bel-7402 cells; plate colony formation assay was used to evaluate the effect of kaempferol on cell colony formation ability; wound healing assay and Transwell chamber were used to observe the effect of kaempferol on cell migration and invasion; Western blot was used to measure the expression of apoptosis-and cycle-related proteins. A one-way analysis of variance was used for comparison between multiple groups,and the least significant difference t-test was used for further comparison between two groups. Results After 24 hours of treatment,the cell viability was 100. 00% ± 2. 72% in the control group and 75. 70% ± 2. 42%,62. 79% ± 2. 45%,and 43. 41% ± 2. 11%,respectively,in the low-,middle-,and high-concentration experimental groups,and compared with the control group,the experimental groups had a significant reduction in cell viability( all P < 0. 05).The number of cell colonies was 923. 3 ± 35. 2 in the control group and 682. 7 ± 24. 4,464. 0 ± 22. 0,and 327. 3 ± 14. 0,respectively,in the low-,middle-,and high-concentration experimental groups,and compared with the control group,the experimental groups had a significant reduction in cell colony formation ability( all P < 0. 05). After 24 hours of treatment,the relative migration rate was 100. 00% ± 1. 11% in the control group and 63. 33% ± 1. 16%,51. 72% ± 3. 23%,and 37. 18% ± 2. 71%,respectively,in the low-,middle-,and high-concentration experimental groups,and the number of transmembrane cells was 212. 0 ± 3. 0 in the control group and 134. 0 ± 2. 0,71. 0 ±2. 0,and 34. 0 ± 1. 0,respectively,in the low-,middle-,and high-concentration experimental groups; compared with the control group,the experimental groups had significant reductions in relative migration rate and number of transmembrane cells( all P < 0. 05). After48 hours of treatment,compared with the control group,the low-,middle-,and high-concentration experimental groups had a significant reduction in the expression of the anti-apoptotic protein Bcl-2( all P < 0. 05),a significant increase in the expression of the pro-apoptotic protein Bax( all P < 0. 05),and a significant reduction in the expression of C < italic/> yclinD1( all P < 0. 05). Conclusion Kaempferol can inhibit the proliferation,migration,and invasion of human hepatoma Bel-7402 cells and promote the apoptosis of such cells,possibly by regulating the apoptosis proteins Bax and Bcl-2 and downregulating the expression of CyclinD1.
[1] BRAY F,FERLAY J,SOERJOMATARAM I,et al. Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin,2018,68(6):394-424.
|
[2] TESTINO G,LEONE S,PATUSSI V,et al. Hepatocellular carcinoma:Diagnosis and proposal of treatment[J]. Minerva Med,2016,107(6):413-426.
|
[3] RADES D,BOLM L,SCHILD SE,et al. Survival following palliative external-beam radiotherapy of locally advanced and metastatic liver cancer[J]. Anticancer Res,2017,37(1):203-206.
|
[4] HUANG WW,CHIU YJ,FAN MJ,et al. Kaempferol induced apoptosis via endoplasmic reticulum stress and mitochondriadependent pathway in human osteosarcoma U-2 OS cells[J]. Mol Nutr Food Res,2010,54(11):1585-1595.
|
[5] TSIKLAURI L,AN G,RUSZAJ DM,et al. Simultaneous determination of the flavonoids robinin and kaempferol in human breast cancer cells by liquid chromatography-tandem mass spectrometry[J]. J Pharm Biomed Anal,2011,55(1):109-113.
|
[6] LI W,DU B,WANG T,et al. Kaempferol induces apoptosis in human HCT116 colon cancer cells via the ataxia-telangiectasia mutated-p53 pathway with the involvement of p53 upregulated modulator of apoptosis[J]. Chem Biol Interact,2009,177(2):121-127.
|
[7] LLOVET JM,VILLANUEVA A,LACHENMAYER A,et al. Advances in targeted therapies for hepatocellular carcinoma in the genomic era[J]. Nat Rev Clin Oncol,2015,12(8):436.
|
[8] VILLANUEVA A,HERNANDEZ-GEA V,LLOVET JM. Medical therapies for hepatocellular carcinoma:A critical view of the evidence[J]. Nat Rev Gastroenterol Hepatol,2013,10(1):34-42.
|
[9] JIN F,WANG Y,LI M,et al. MiR-26 enhances chemosensitivity and promotes apoptosis of hepatocellular carcinoma cells through inhibiting autophagy[J]. Cell Death Dis,2017,8(1):e2540.
|
[10] ZHU G,LIU X,LI H,et al. Kaempferol inhibits proliferation,migration,and invasion of liver cancer HepG2 cells by downregulation of microRNA-21[J]. Int J Immunopathol Pharmacol,2018,32:2058738418814341.
|
[11] HUANG WW,TSAI SC,PENG SF,et al. Kaempferol induces autophagy through AMPK and AKT signaling molecules and causes G2/M arrest via downregulation of CDK1/cyclin B in SK-HEP-1 human hepatic cancer cells[J]. Int J Oncol,2013,42(6):2069-2077.
|
[12] NAULT JC. The end of almost 10 years of negative RCTs in advanced hepatocellular carcinoma[J]. Lancet,2017,389(10064):4-6.
|
[13] LIU PH,HSU CY,HSIA CY,et al. Prognosis of hepatocellular carcinoma:Assessment of eleven staging systems[J]. J Hepatol,2016,64(3):601-608.
|
[14] YANG F,LI L,CHEN K,et al. Melatonin al eviatesβ-zearalenol and HT-2 toxin-induced apoptosis and oxidative stress in bovine ovarian granulosa cells[J]. Environ Toxicol Pharmacol,2019,68:52-60.
|
[15] ZHANG X,QI Z,YIN H,et al. Interaction between p53 and Ras signaling controls cisplatin resistance via HDAC4-and HIF-1α-mediated regulation of apoptosis and autophagy[J]. Theranostics,2019,9(4):1096-1114.
|
[16] CHOI MS,MOON SM,LEE SA,et al. Erratum:Adenosine induces intrinsic apoptosis via the PI3K/Akt/m TOR signaling pathway in human pharyngeal squamous carcinoma Fa Du cells[J]. Oncol Lett,2019,17(3):3615.
|
[17] DASARI R,BANULS LM,MASI M,et al. C1,C2-ether derivatives of the Amaryllidaceae alkaloid lycorine:Retention of activity of highly lipophilic analogues against cancer cells[J].Bioorg Med Chem Lett,2014,24(3):923-927.
|
[18] LI H,LV B,KONG L,et al. Nova1 mediates resistance of rat pheochromocytoma cells to hypoxia-induced apoptosis via the Bax/Bcl-2/caspase-3 pathway[J]. Int J Mol Med,2017,40(4):1125-1133.
|
[19] STOCKER G,OTT K,HENNINGSEN N,et al. CyclinD1 and interleukin-1 receptor antagonist polymorphisms are associated with prognosis in neoadjuvant-treated gastric carcinoma[J]. Eur J Cancer,2009,45(18):3326-3335.
|
[1] | Zhiru WANG, Wenjing ZHAO, Xi CHEN. Effect and mechanism of gallic acid on the proliferation, migration, invasion, and apoptosis of human hepatocellular carcinoma HepG2 cells[J]. Journal of Clinical Hepatology, 2025, 41(3): 493-498. doi: 10.12449/JCH250315 |
[2] | Junzhe CAI, Songbai LIU, Xiaobin FEI, Peng LIU, Changhao ZHU, Xing WANG, Yaozhen PAN. Effect of ankyrin-repeat domain-containing protein 22 on human hepatoma cells and its mechanism[J]. Journal of Clinical Hepatology, 2024, 40(5): 989-996. doi: 10.12449/JCH240519 |
[3] | Lina BAI, Ying LIU, Chunxiao TANG, Hongxin PIAO, Zhenhua LIN, Wanshan YANG, Aihua JIN. Mechanism of carrimycin in regulating the biological function of pancreatic cancer cells[J]. Journal of Clinical Hepatology, 2022, 38(12): 2793-2801. doi: 10.3969/j.issn.1001-5256.2022.12.020 |
[4] | Jianan ZHAO, Jinghua PENG, Ping LIU, Yiyang HU. Effect of Cordyceps polysaccharides on hepatocyte apoptosis induced by tumor necrosis factor-α[J]. Journal of Clinical Hepatology, 2021, 37(6): 1368-1372. doi: 10.3969/j.issn.1001-5256.2021.06.029 |
[5] | Lu Qian, Cheng Xin, Xia ZhenGuo, Chen Zhong. Effect of proteasome subunit beta type 4 on the proliferation and viability of human liver cancer SMMC7721 cells[J]. Journal of Clinical Hepatology, 2020, 36(3): 592-595. doi: 10.3969/j.issn.1001-5256.2020.03.024 |
[6] | Wang ZeXin, Guan LiJun, Li JianMing, Wang ZhiChao, Xue MengRuo, Qin XiaoJun. Effect of targeted regulation of the Wnt2 gene by microRNA( microRNA-21) on the proliferation and migration of HepG2 hepatoma cells[J]. Journal of Clinical Hepatology, 2020, 36(4): 803-807. doi: 10.3969/j.issn.1001-5256.2020.04.019 |
[7] | Xiao ErHui, Ning HuiBin, Kang YueHua, Yin Hui, Ma Li, Mao ZhongShan, Zhao Yan, Shang Jia. Downregulation of miR-196b in regulating the growth and apoptosis of hepatoma cells by targeting nuclear apoptosis-inducing factor 1[J]. Journal of Clinical Hepatology, 2020, 36(10): 2230-2235. doi: 10.3969/j.issn.1001-5256.2020.10.014 |
[8] | Zhang Yang, Chen ShuYing, Xu GuangRu. Effect of extracellular ubiquitin on the proliferation,invasion,and migration of hepatoma cells[J]. Journal of Clinical Hepatology, 2020, 36(6): 1289-1292. doi: 10.3969/j.issn.1001-5256.2020.06.020 |
[9] | Zhu YueKun, Zhao XianQi, Wang DaWei, Zhang Wei, Tian MaoLin, Li ZhengTian, Zhao Long, Li Chao, Jiang HongChi. Effect of cyclooxygenase-2 antisense RNA combined with celecoxib on the proliferation and apoptosis of hepatoma cells[J]. Journal of Clinical Hepatology, 2018, 34(12): 2614-2618. doi: 10.3969/j.issn.1001-5256.2018.12.021 |
[10] | Li YingYing, Zhan LiFen, Ceng ZheChao, Xu Shen. Effect of lobaplatin on proliferation and apoptosis of hepatocellular carcinoma HepG2 cells and related mechanism of action[J]. Journal of Clinical Hepatology, 2018, 34(4): 784-788. doi: 10.3969/j.issn.1001-5256.2018.04.018 |
[11] | Sha Liang, He JianBo, Li KeZhi, Chen Chuang, Huang Shan, Zhao YinNong, Lian Fang, Wu GuoBin. Influence of specific down-regulation of LKB1 expression on invasion and migration of hepatoma cells[J]. Journal of Clinical Hepatology, 2017, 33(5): 875-879. doi: 10.3969/j.issn.1001-5256.2017.05.016 |
[12] | Geng YaJun, Li ShuDong, Liu ShenZheng, Ren JianJun, Zhang Tong. Inhibitory effect of microRNA-149-5p in the proliferation and migration of HepG2 and Bel-7402 hepatoma cells[J]. Journal of Clinical Hepatology, 2017, 33(6): 1126-1130. doi: 10.3969/j.issn.1001-5256.2017.06.022 |
[13] | Zhang ChaoYa, Zhao XiangXuan, Lu ZaiMing, Guo QiYong. Research advances in sorafenib- induced apoptotic signaling pathways in liver cancer cells[J]. Journal of Clinical Hepatology, 2016, 32(4): 816-820. doi: 10.3969/j.issn.1001-5256.2016.04.048 |
[14] | Pan LiuLan, Jia ShengNan, Ma JingTing, Tai JingHua, Jin ZhenJing. Effect of decoy receptor 3 gene on hepatocyte apoptosis[J]. Journal of Clinical Hepatology, 2016, 32(7): 1330-1333. doi: 10.3969/j.issn.1001-5256.2016.07.023 |
[15] | Du SenRong, Mao XiaoRong, Xiao Ping, Chen Hong. Effects of PARP-1 inhibitors AG-014699 and AZD2281 on proliferation and apoptosis of human hepatoma cell line HepG2[J]. Journal of Clinical Hepatology, 2015, 31(6): 943-946. doi: 10.3969/j.issn.1001-5256.2015.06.027 |
[16] | Xu Li, Ma KeXin, Dong Bing, Liu HaiWang, Liu QinLong, Gao ZhenMing, Sun DeGuang, Zhang RiXin, Wang HaiBo, Wang LiMing, Liang Rui. Regulatory effect of miRNAs on apoptosis, migration, and cell cycle of hepatocellular carcinoma cells[J]. Journal of Clinical Hepatology, 2013, 29(7): 554-557. |
[17] | Shen Bo, Nie YuQiang. Peroxisome proliferator- activated receptor gamma inhibits liver cancer proliferation and metastasis in vitro[J]. Journal of Clinical Hepatology, 2013, 29(9): 702-706. doi: 10.3969/j.issn.1001-5256.2013.09.018 |
[18] | Jia XiaoLi, Shi JuanJuan, Feng Ting, Cheng YanAn, Wang Rui, Liu JingKun, Dang ShuangSuo. Effects of guggulsterone on proliferation and apoptosis of HepG2 human hepatocellular carcinoma cells[J]. Journal of Clinical Hepatology, 2013, 29(6): 452-455. |
[19] | Tai BoJun, Yao Min, Gu Xing, Shi Yun, Yu DanDan, Chen Jie, Zheng WenJie, Yao DengFu, Lu ShaoLin. Effects of silencing glypican- 3 gene transcription on proliferation and apoptosis of hepatoma cells[J]. Journal of Clinical Hepatology, 2013, 29(11): 863-866. doi: 10.3969/j.issn.1001-5256.2013.10.015 |
[20] | Qiao ChunPing, Chen YueXiang. Advances in study of the relationship between apoptosis and alcoholic liver disease[J]. Journal of Clinical Hepatology, 2012, 28(5): 386-390. |
1. | 龚飞,吴思明,徐磊,林宇,马德翊,韩翠翠. 17-羟-岩大戟内酯B对肝癌BEL-7402细胞增殖和凋亡的影响及机制. 齐齐哈尔医学院学报. 2023(08): 701-705 . ![]() | |
2. | 眭玉霞,庄捷,庄敏,黄桂. Delicaflavone通过PI3K/AKT/mTOR通路调控上皮-间质转化抑制吉非替尼耐药肺癌PC-9/GR细胞迁移和侵袭. 中国临床药理学与治疗学. 2022(06): 614-621 . ![]() | |
3. | 杨雪丽,薛建华,陈天阳,平键,侯天禄,陈建杰,成扬. 苍术酮对肝癌HepG2细胞活性、凋亡的影响及其相关机制. 临床肝胆病杂志. 2021(11): 2589-2594 . ![]() |